A detailed history of Quest Partners LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Quest Partners LLC holds 5,788 shares of CELC stock, worth $87,051. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,788
Previous 4,409 31.28%
Holding current value
$87,051
Previous $95.2 Million 0.45%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$14.1 - $20.78 $19,443 - $28,655
1,379 Added 31.28%
5,788 $94.8 Million
Q1 2024

May 09, 2024

BUY
$13.74 - $21.6 $60,579 - $95,234
4,409 New
4,409 $95.2 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $225M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.